Sublingual versus subcutaneous buprenorphine in opiate abusers

Area of Science:

• Pharmacology
• Clinical Research

Background:

• Buprenorphine is an opioid medication used in addiction treatment.
• Understanding the comparative pharmacologic profiles of different administration routes is crucial for optimizing patient care.

Purpose of the Study:

• To compare the pharmacologic profiles of sublingually and subcutaneously administered buprenorphine.
• To assess the relative potency and effects of buprenorphine via different routes in individuals with a history of opiate abuse.

Main Methods:

• A double-blind, double-dummy, placebo-controlled study involving 10 healthy male subjects with histories of opiate abuse.
• Administration of varying dosages of sublingual and subcutaneous buprenorphine, alongside placebo.
• Assessment of physiologic parameters (miosis, body temperature, blood pressure, heart rate, respiratory rate) and subjective effects (euphoria, dysphoria, sedation) using the Addiction Research Center Inventory.

Main Results:

• All active buprenorphine dosages induced significant miosis without notable changes in vital signs.
• Buprenorphine administration resulted in dose- and route-dependent euphoria, with minimal dysphoria and sedation.
• Subject and observer ratings indicated significant "liking" for buprenorphine.
• The relative potency of sublingual to subcutaneous buprenorphine was calculated to be approximately two-thirds for both physiologic and behavioral effects.

Conclusions:

• Sublingual and subcutaneous buprenorphine exhibit similar pharmacologic effect profiles in individuals with a history of opiate abuse.
• The findings support the efficacy of both administration routes, with quantifiable differences in potency.
• This research provides valuable data for clinical decision-making regarding buprenorphine administration in opioid use disorder treatment.